Stocks Health care OGI
NASDAQ · Health careOrganigram Global Inc. (OGI)
Organigram Global Inc. reported revenue of CA$159.8M in fiscal 2024. It posted a net loss of CA$45.4M. In fiscal 2024 capital spending exceeded operating cash flow by CA$859K. Its latest periodic report to the SEC is the annual report (Canadian issuer) (40-F) filed on December 16, 2025.
Key facts about Organigram Global Inc.
- Net worth
- Organigram Global Inc. has a market value (market cap) of $122.3M at the latest share price, and shareholders' equity of CA$306M on its balance sheet at September 30, 2024. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2024 revenue was CA$159.8M (+9.6% year on year), with a net loss of CA$45.4M.
- Cash flow
- In fiscal 2024 operations brought in CA$3.9M of cash; after CA$4.7M of capital spending, free cash flow was -CA$859K.
- Latest report
- The latest periodic report (annual report (Canadian issuer), 40-F) was filed with the SEC on December 16, 2025 and covers the period to September 30, 2025. Open on SEC EDGAR
What Organigram Global Inc. does
Organigram Global Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker OGI.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2024 | CA$159.8M | -CA$45.4M | -CA$0.48 | -CA$859K |
| 2022 | CA$145.8M | -CA$14.3M | -CA$0.18 | -CA$85M |
| 2021 | CA$79.2M | -CA$130.7M | -CA$2.04 | -CA$40.3M |
| 2020 | CA$86.8M | -CA$136.2M | -CA$3.16 | -CA$122.3M |
| 2019 | CA$80.4M | -CA$9.5M | -CA$0.27 | -CA$143.8M |
| 2019 | CA$12.4M | CA$20.5M | CA$0.65 | -CA$69.1M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Organigram Global Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 3, 2026
- October 15, 2026
- September 30, 2026
- September 3, 2026
- September 1, 2026
- August 20, 2026
- August 11, 2026
- August 4, 2026
- July 20, 2026
- May 12, 2026
Insider trades
What the people running Organigram Global Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Who owns OGI
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| BT DE Investments Inc.13D, may seek influence with 1 related filers | 29.9% | April 17, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 1 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| FNY Investment Advisers, LLC | 3,150 | new |
Insiders
Questions about OGI
What does Organigram Global Inc. do?
Organigram Global Inc. is a company in the Health care sector, listed on NASDAQ as OGI. Its shares trade on NASDAQ under the ticker OGI.
What is Organigram Global Inc.'s net worth?
Organigram Global Inc. has a market value (market cap) of $122.3M at the latest share price, and shareholders' equity of CA$306M on its balance sheet at September 30, 2024. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Organigram Global Inc. profitable?
No. In fiscal 2024 it reported a net loss of CA$45.4M on revenue of CA$159.8M.
How much revenue does Organigram Global Inc. make?
In fiscal 2024 Organigram Global Inc. reported revenue of CA$159.8M.
When did Organigram Global Inc. last report?
Its most recent periodic report is the annual report (Canadian issuer) (40-F) filed on December 16, 2025. It covers the period to September 30, 2025. Its newest filing of any kind is the foreign issuer update from November 3, 2026.
Similar companies
Compare OGI with
Follow OGI
Get an email when Organigram Global Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Organigram Global Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.